News

FDA tells food producers to cut the trans fat


 

References

Food manufacturers will no longer be allowed to include partially hydrogenated oils (PHOs) in human food when a new requirement by the Food and Drug Administration becomes effective.

The FDA finalized its determination that PHOs, which are the primary dietary source of artificial trans fat in processed foods, are not “generally recognized as safe” for use in human food. This action was preceded by the FDA having requested comment on a tentative version of the determination in a Nov. 8, 2013 notice.

©Mark Poprocki/Thinkstockphotos.com

“This determination is based on extensive research into the effects of PHOs, as well as input from all stakeholders received during the public comment period,” said Susan Mayne, Ph.D., director of the FDA’s Center for Food Safety and Applied Nutrition, in a written statement.

The order follows the FDA’s requirement that food manufacturers include trans fat content information on nutrition facts labels, which became effective in 2006. Currently, the FDA allows companies to state on the labels of foods containing less than 0.5 grams of trans fat per serving that such foods are made with 0 grams of trans fat.

The FDA’s new requirement “is expected to reduce coronary heart disease and prevent thousands of fatal heart attacks every year,” said the FDA’s Acting Commissioner Stephen Ostroff in the written statement.

The agency is giving food producers 3 years to remove PHOs from their products and/or petition the FDA to permit specific uses of PHOs. A notice of the order is scheduled to be published in the Federal Register tomorrow (June 17, 2015).

klennon@frontlinemedcom.com

Recommended Reading

No difference between losartan and atenolol treatments for aortic-root dilation
MDedge Pediatrics
Children with NAFLD and high blood pressure more likely to develop cardiovascular issues
MDedge Pediatrics
Psychosocial factors in childhood influence cardiovascular health in adulthood
MDedge Pediatrics
Study evaluates benefit of fetal growth ultrasound in detecting SGA
MDedge Pediatrics
Dabigatran response in children’s blood is consistent through age groups
MDedge Pediatrics
Poor diet hampers children’s cardiovascular health
MDedge Pediatrics
Children of smokers twice as likely to develop carotid atherosclerotic plaque
MDedge Pediatrics
Recommended statin use in young adults greatly expanded under pediatric rules
MDedge Pediatrics
Newborn’s pulmonary hypertension risk up slightly after SSRI exposure in pregnancy
MDedge Pediatrics
IHC: IV dihydroergotamine linked to increased thrombosis risk
MDedge Pediatrics